NetworkNewsBreaks Archive - Page 1941 of 2081

MondaySep 18, 2017 12:00 pm

NetworkNewsBreaks – Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR) Has “Buy” Rating Reiterated at Mizuho Securities

Mizuho Securities USA LLC has reiterated its ‘Buy’ rating and price target of $32 on shares of Alder BioPharmaceuticals, Inc.’s (NASDAQ: ALDR) stock after Mizuho received an email from the company reviewing the 18th Congress of the International Headache Society (IHC) meeting. The email included incremental data points regarding Alder’s lead pivotal-stage product candidate, eptinezumab. The analyst believes that the IV formulation for eptinezumab is a positive distinction from other calcitonin gene-related peptide (CGRP) products in late stage development, based on its reimbursement and potentially improved compliance. For more information, visit www.AlderBio.com About Alder BioPharmaceuticals, Inc. Alder BioPharmaceuticals, Inc. is…

MondaySep 18, 2017 10:55 am

NetworkNewsBreaks – Global Payout, Inc. (GOHE) Subsidiary Attends Cannabis World Congress & Business Exposition

Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced that executive management members of its majority-owned subsidiary, MoneyTrac Technology, Inc., successfully represented the company at the fourth annual Cannabis World Congress & Business Exposition held in Los Angeles. “Representation at events such as this present such a unique and powerful opportunity to grow our presence and establish new partnerships within an industry that is incredibly tight-knit and yet growing at an unprecedented rate,” MoneyTrac COO Vanessa Luna stated in the news release. “I am encouraged by the many different connections we established during this expo, and I am…

MondaySep 18, 2017 10:20 am

NetworkNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Nets Total Proceeds of $11.9 Million from Exercise of Warrants

ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) this morning announced that it has received total proceeds of nearly $11.9 million from the exercise of an aggregate of 19,185,965 warrants since the closing of its acquisition of ABcann Medicinals Inc. on April 28, 2017. With these funds, ABcann’s current cash position stands at approximately $45 million, giving the company the means to execute previously outlined plans to expand its production capabilities. “ABcann thanks our shareholders for their continued support and confidence as we work toward expanding our facilities and increasing production,” Aaron Keay, director and CEO of ABcann, stated in the…

MondaySep 18, 2017 9:45 am

NetworkNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Provides Update on Data Showing Effectiveness of THC in Addressing Underlying Cause of Alzheimer’s

India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning provided an update on compelling in vitro data compiled from genetically engineered cell lines within an Alzheimer’s disease model. Per the update, the aggregation of Aβ protein in the cerebral cortex and hippocampus, which is believed to be a primary cause of Alzheimer’s disease, is decreased by as much as 40 percent when treated with varying concentrations of THC. “As Alzheimer’s progresses, synaptic dysfunction and the death of neurons lead to memory loss,” Ram Mukunda, CEO of IGC, stated…

MondaySep 18, 2017 9:16 am

NetworkNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Subsidiary Completes China FDA Filing; Moves toward Launch of Hemp-Infused Skin Care Line

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX), through wholly-owned subsidiary CBD Biotechnology Co. Ltd., this morning announced that it has completed the record filing process with the China Food & Drug Administration (“CFDA”) for its first line of non-industrial hemp-infused skin care products. Following this milestone, the company expects to launch its ‘CBD Magic Hemp Series’ skin care line in the next couple of months, effectively positioning CBD Biotechnology as a leader in what the company has called “an untapped segment of China’s skin care industry.” "I am very pleased to announce the upcoming launch of CBD Biotechnology's non-industrial hemp-infused…

FridaySep 15, 2017 12:34 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on September 15, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: SLNO 17.4% – News: Data from the pilot clinical trial of DCCR were presented at the 10th International Meeting of Pediatric Endocrinology MBOT 15.5% – News: Awarded patent for TipCAT technology platform from Intellectual Property India JAGX 8.0% – News: Napo Pharmaceuticals, Inc. subsidiary hires experienced HIV and GI drug sale reps in key U.S. markets RXII 9.2% – News: BioAxone BioSciences’ collaboration with RXi Pharmaceuticals Corp. awarded two-year grant to further develop BioAxone’s…

FridaySep 15, 2017 12:34 pm

NetworkNewsBreaks – Organigram (TSX.V: OGI) (OTCQB: OGRMF) Signs MOU with Canadian Provincial Authority for Distribution of Cannabis to Adult Recreational Market

Organigram Holdings Inc. (TSX.V: OGI) (OTCQB: OGRMF), a leading licensed producer of medical marijuana based in Moncton, New Brunswick, today announced it has entered into a memorandum of understanding (MOU) with the New Brunswick provincial authority for the distribution of marijuana to the adult-use recreational market. Through the MOU, New Brunswick secures a supply of at least five million grams of recreational marijuana per year from Organigram. In a news release, Organigram CEO Greg Engel said, “We applaud the New Brunswick government’s efforts to foster an innovative, forward-thinking economic climate that supports cannabis as a driver of growth for New…

FridaySep 15, 2017 12:33 pm

NetworkNewsBreaks – University of British Columbia to Conduct Clinical Study of Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQB: LXRP) Game-Changing Oral CBD Product

While cannabidiol and other marijuana-derived substances are traditionally smoked, this can cause damage to the lungs, and edible cannabis products have their drawbacks, too—typically being filled with sugars or other sweeteners to mask the unpleasant flavor associated with cannabis compounds. With its pioneering TurboCBD™ product, however, Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has revolutionized oral CBD intake, having engineered the product to enhance absorption through the intestinal tract without active compounds being destroyed by stomach acid or broken down by the liver, and this revolutionary product also masks the unpleasant flavor of cannabis compounds. An article further discussing this…

FridaySep 15, 2017 12:28 pm

NetworkNewsBreaks – AppSwarm, Inc. (SWRM) Leverages Growth Strategy by Focusing on Key Revenue Streams

Building on $589,000 in revenue earned in 2016, AppSwarm, Inc. (OTC: SWRM) is going strong in 2017 with a vigorous growth strategy that is centered on a proprietary business model, known internally as the “Swarm.” This strategy involves measures like in-house development and assets gained through mergers and acquisitions. An article further discussing this topic reads: “The four key revenue streams driving the company’s progress include the incubation of apps, using completion of concept and development, market analysis, sales/marketing, and financial management services. AppSwarm is also highly engaged in social game development. It has developed highly relevant concepts internally, although…

FridaySep 15, 2017 12:26 pm

NetworkNewsBreaks – Algae Dynamics Corp. (ADYNF) Collaborates with Prominent Neuroscientist to Research Cannabinoid Potential in Treating Mental Health Disorders

Algae Dynamics Corp. (OTCQB: ADYNF), a Canadian company engaged in developing proprietary research as well as products derived from cannabis and hemp oils, has commenced a collaborative relationship with Dr. Laviolette, a neuroscientist at the University of Western Ontario, Canada, who is examining the treatment potential of cannabinoids in addressing disorders like addiction, schizophrenia, depression and post-traumatic stress disorder. Dr. Laviolette has been seeking ways to more effectively utilize chemicals found in marijuana to treat some of these illnesses, while Algae Dynamics has been taking a holistic approach by examining specific cannabinoids found in marijuana and combining that research with…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks